C099-0757 Screening compound: 4-[6-({2-[3-(4-bromophenyl)-5-(2,3-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}sulfanyl)-4-oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-1-yl]benzene-1-sulfonamide

C099-0757 Screening compound: 4-[6-({2-[3-(4-bromophenyl)-5-(2,3-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}sulfanyl)-4-oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-1-yl]benzene-1-sulfonamide
C099-0757 Screening compound: 4-[6-({2-[3-(4-bromophenyl)-5-(2,3-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}sulfanyl)-4-oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-1-yl]benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C099-0757
4-[6-({2-[3-(4-bromophenyl)-5-(2,3-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}sulfanyl)-4-oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-1-yl]benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C099-0757

Molecular Formula

C30H26BrN7O6S2 (C30 H26 BrN7 O6 S2)

Compound Name

4-[6-({2-[3-(4-bromophenyl)-5-(2,3-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}sulfanyl)-4-oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-1-yl]benzene-1-sulfonamide

IUPAC name

4-[6-({2-[3-(4-bromophenyl)-5-(23-dimethoxyphenyl)-45-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}sulfanyl)-4-oxo-1H4H5H-pyrazolo[34-d]pyrimidin-1-yl]benzene-1-sulfonamide

SMILES

COc1cccc(C(C2)N(C(CSC(N3)=Nc(n(-c(cc4)ccc4S(N)(=O)=O)nc4)c4C3=O)=O)N=C2c(cc2)ccc2Br)c1OC

InChI

InChI=1S/C30H26BrN7O6S2/c1-43-25-5-3-4-21(27(25)44-2)24-14-23(17-6-8-18(31)9-7-17)36-38(24)26(39)16-45-30-34-28-22(29(40)35-30)15-33-37(28)19-10-12-20(13-11-19)46(32,41)42/h3-13,15,24H,14,16H2,1-2H3,(H2,32,41,42)(H,34,35,40)/t24-/m1/s1

InChI Key

CFKQAWPMLNQDAC-XMMPIXPASA-N

MDL Number (MFCD)

MFCD04456668

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

724.62

Hydrogen Bond Acceptors Count

15.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

13

Partition Coefficient, logP

4.247

Distribution Coefficient, logD

4.184

Water Solubility, LogSw

-4.42

Polar Surface Area

141.023

Acid Dissociation Constant (pKa)

8.21

Base Dissociation Constant (pKb)

0.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.70

C099-0757 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C099-0757 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C099-0757?
Check Price and Availability of C099-0757, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C099-0757 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C099-0757
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C099-0757
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C099-0757 available by request